Arcellx Alternatives & Competitors
12 companies similar to Arcellx — Arcellx is a clinical-stage biotechnology company based in Redwood City, Califor...
Companies similar to Arcellx
Interius BioTherapeutics
Interius is developing new ways to engineer cells inside the human body, right where they...
Philadelphia, United Stat...
Kite Pharma
At Kite, a Gilead Company, our singular focus is cell therapy to treat and cure cancer.
Santa Monica, United Stat...
Germany
LAVA Therapeutics N.V.
Developing next generation bispecific gamma-delta T cell engaging (bsTCE) antibodies to fi...
Utrecht, The Netherlands
Rival Readout
Competing with Arcellx? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Legend Biotech
Multinational biopharmaceutical company focused on discovering and developing cutting-edge...
Somerset, United States
Adaptimmune
Designing and delivering cell therapies to transform the lives of people with cancer.
Abingdon, United Kingdom
Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent...
New Haven, United States
NexImmune, Inc.
NexImmune, Directing T cell function to restore natural immunity
Gaithersburg, United Stat...
Kestrel Therapeutics
We aspire to invent brilliant technologies for difficult cancer targets, beginning with mu...
Watertown, United States
Lineage Cell Therapeutics
A clinical-stage biotechnology company developing novel cell therapies for unmet medical n...
Carlsbad, United States
ARTBIO
Channeling Energy. Changing Lives.
Cambridge, United States
About Arcellx
Arcellx, founded in 2015, is a clinical-stage biotechnology company headquartered in the United States. Specializing in biopharma, biotechnology, health care, life sciences, and pharmaceuticals, the company has made significant strides in the realm of cell therapy. As of its last major development, Arcellx became part...
Cell Therapy Development, Clinical Trials Execution, Therapy Manufacturing, Research for Novel Therapies
Cancer Patients, Healthcare Providers, Medical Researchers, Investors in Biotechnology
Clinical-stage, Cell Therapy, Immunotherapy, Cancer Treatment, Multiple Myeloma, Acute Myeloid Leukemia, CART-ddBCMA, ARC-SparX, Controlled CAR-T Therapy, Relapsed Or Refractory Diseases, Orphan Drug Designation, Regenerative Medicine, Pharmaceutical Innovation, Oncology
B2B, B2D
Licensing, Product Sales, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Arcellx: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Arcellx on 3 Jul 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
